anti-estrogen therapy
Showing 1 - 25 of >10,000
Hormone Receptor-positive Breast Cancer Trial (LACUDY)
Not yet recruiting
- Hormone Receptor-positive Breast Cancer
- (no location specified)
Dec 6, 2022
Hot Flushes, Hot Flashes Trial in Chicago (Bupivicaine, Saline)
Completed
- Hot Flushes
- Hot Flashes
-
Chicago, IllinoisNorthwestern University Feinberg School of Medicine
Dec 16, 2021
Metastatic Breast Cancer Trial in Springfield, Rochester, Lebanon (17B-estradiol, Letrozole, Anastrozole)
Active, not recruiting
- Metastatic Breast Cancer
- 17B-estradiol
- +3 more
-
Springfield, Massachusetts
- +2 more
Nov 1, 2022
Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in Bellevue, Grand Island, Omaha (drug, other,
Active, not recruiting
- Estrogen Receptor Negative
- +15 more
- Cyclophosphamide
- +6 more
-
Bellevue, Nebraska
- +3 more
Nov 30, 2022
Metastatic Breast Cancer, Breast Carcinoma Trial in United States (LEE-011, Fulvestrant, Placebo)
Active, not recruiting
- Metastatic Breast Cancer
- Breast Carcinoma
- LEE-011
- +2 more
-
Birmingham, Alabama
- +12 more
Feb 17, 2022
Edema, Erythema, Estrogen Receptor Negative Trial in Houston (Laboratory Biomarker Analysis, Pembrolizumab)
Active, not recruiting
- Edema
- +8 more
- Laboratory Biomarker Analysis
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Jan 23, 2023
Covid-19 Trial in Mexico City (Estrogen Therapy)
Active, not recruiting
- Covid-19
- Estrogen Therapy
-
Mexico City, Benito Juárez, MexicoCMN "20 de Noviembre"
Jul 7, 2022
Collecting, Analyzing, and Storing Samples From Metastatic,
Terminated
- Estrogen Receptor Negative
- +4 more
- Cytology Specimen Collection Procedure
- +3 more
-
Seattle, Washington
- +1 more
Sep 23, 2021
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Trial (Giredestrant, Fulvestrant, Abemaciclib)
Not yet recruiting
- Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
- Giredestrant
- +6 more
- (no location specified)
Sep 26, 2023
Subfertility, Female Trial in Bani Suwayf (estrogen therapy)
Completed
- Subfertility, Female
- estrogen therapy
-
Banī Suwayf, EgyptBeni-suef university
Mar 1, 2023
Stress Urinary Incontinence, Postmenopausal Disorder Trial in Cairo (TVT-O)
Completed
- Stress Urinary Incontinence
- Postmenopausal Disorder
- TVT-O
-
Cairo, EgyptKasr El Ainiy Hospital
Oct 21, 2022
Menopausal Symptoms Trial in Stockholm (Micronized progesterone in continuous combination with oral estrogen, Norethisterone
Recruiting
- Menopausal Symptoms
- Micronized progesterone in continuous combination with oral estrogen
- Norethisterone acetate in continuous combination with oral estrogen
-
Stockholm, SwedenKarolinska University Hospital
Oct 21, 2022
Breast Cancer Trial in Orange City (ARV-471 (PF-07850327), Palbociclib, Letrozole)
Recruiting
- Breast Cancer
- ARV-471 (PF-07850327)
- +2 more
-
Orange City, FloridaMid Florida Hematology and Oncology Center
Jun 8, 2023
PTSD Trial in Philadelphia (Estradiol, Placebo oral tablet)
Recruiting
- PTSD
- Estradiol
- Placebo oral tablet
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Perelman School of Medicine
Jan 30, 2023
Metastatic Cancer, Breast Cancer, Lobular Breast Carcinoma Trial in Madison (18F-fluorofuranylnorprogesterone, Liquid Biopsy,
Recruiting
- Metastatic Cancer
- +2 more
- 18F-fluorofuranylnorprogesterone
- +2 more
-
Madison, WisconsinUW Carbone Cancer Center
Oct 10, 2023
Compare Vaginal Estrogen and Platelet-rich Plasma Over
Not yet recruiting
- Menopause
- +3 more
- Vaginal estrogen supplement
- Platelet-rich plasma injection
- (no location specified)
Aug 3, 2022
Effect of Estrogen Treatment on Drug Metabolism and Transport
Not yet recruiting
- Transgender Persons
- Midazolam oral solution
- +2 more
- (no location specified)
Jul 19, 2022
Hypertension, Pulmonary Arterial Hypertension, Familial Primary Pulmonary Hypertension Trial in Nashville (Tamoxifen, Placebo
Recruiting
- Hypertension
- +8 more
- Tamoxifen
- Placebo Oral Tablet
-
Nashville, TennesseeVanderbilt University Medical Center
Aug 22, 2022
Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor, Radiotherapy Trial in Guangzhou (Toripalimab,
Not yet recruiting
- Muscle-Invasive Bladder Carcinoma
- +2 more
- Toripalimab
- +4 more
-
Guangzhou, Guangdong, ChinaCancer Center, Sun Yat-sen University
Aug 3, 2023
Therapy of Anti-NMDAR Encephalitis at Diagnosis
Active, not recruiting
- Anti-NMDA (N-Methyl D-Aspartate) Receptor Encephalitis
-
Rotterdam, NetherlandsErasmus Medical Center
Sep 4, 2023
Hormones on Frequency of Headache and Brain Structure and
Recruiting
- Headache
- Gender Identity
- Clinical estrogen therapy
-
Aurora, ColoradoChildren's Hospital Colorado
Oct 31, 2022